Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C3KE
|
|||
Former ID |
DIB019323
|
|||
Drug Name |
PMID21627121C2
|
|||
Synonyms |
GTPL8149; BDBM50418829
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C15H11ClN2O2
|
|||
Canonical SMILES |
C1=CNC(=C1)C=C2C3=C(C=CC(=C3)C(=O)CCl)NC2=O
|
|||
InChI |
1S/C15H11ClN2O2/c16-8-14(19)9-3-4-13-11(6-9)12(15(20)18-13)7-10-2-1-5-17-10/h1-7,17H,8H2,(H,18,20)/b12-7-
|
|||
InChIKey |
SEPHEVMRHYRRLS-GHXNOFRVSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NIMA-related kinase 2 (NEK2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Irreversible Nek2 kinase inhibitors with cellular activity. J Med Chem. 2011 Jun 23;54(12):4133-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.